| Cabining intellectual property through a property paradigm MA Carrier Duke LJ 54, 1, 2004 | 444 | 2004 |
| Rule of reason: An empirical update for the 21st century MA Carrier Geo. Mason L. Rev. 16, 827, 2008 | 278 | 2008 |
| Unraveling the patent-antitrust paradox MA Carrier U. Pa. L. Rev. 150, 761, 2001 | 274 | 2001 |
| Unsettling drug patent settlements: A framework for presumptive illegality MA Carrier Mich. L. Rev. 108, 37, 2009 | 193 | 2009 |
| The real rule of reason: bridging the disconnect MA Carrier ByU L. Rev., 1265, 1999 | 183 | 1999 |
| Product hopping: a new framework MA Carrier, SD Shadowen Notre Dame L. Rev. 92, 167, 2016 | 152 | 2016 |
| Copyright and innovation: The untold story MA Carrier Wis. L. Rev., 891, 2012 | 137 | 2012 |
| A real-world analysis of pharmaceutical settlements: The missing dimension of product hopping MA Carrier Fla. L. Rev. 62, 1009, 2010 | 103 | 2010 |
| Resolving the patent-antitrust paradox through tripartite innovation MA Carrier Vand. L. Rev. 56, 1047, 2003 | 91 | 2003 |
| Payment After Actavis MA Carrier Iowa L. Rev. 100, 7, 2014 | 89 | 2014 |
| Citizen Petitions: Long, Late-Filed, and at-Last Defined MA Carrier, C Minniti Am. UL Rev. 66, 305, 2016 | 88 | 2016 |
| Innovation for the 21st Century MA Carrier Oxford University Press, USA, 2011 | 87 | 2011 |
| Two puzzles resolved: of the Schumpeter-Arrow stalemate and pharmaceutical innovation markets MA Carrier Iowa L. Rev. 93, 393, 2007 | 78 | 2007 |
| When is the Senate in recess for purposes of the recess appointments clause MA Carrier Mich. L. Rev. 92, 2204, 1993 | 77 | 1993 |
| Citizen petitions: an empirical study MA Carrier, D Wander Cardozo L. Rev. 34, 249, 2012 | 75 | 2012 |
| Biologics: the new antitrust frontier MA Carrier, CJ Minniti III U. Ill. L. Rev., 1, 2018 | 72 | 2018 |
| SOPA, PIPA, ACTA, TPP: An alphabet soup of innovation-stifling copyright legislation and agreements MA Carrier Nw. J. Tech. & Intell. Prop. 11, 21, 2012 | 63 | 2012 |
| Strategies that delay or prevent the timely availability of affordable generic drugs in the United States GH Jones, MA Carrier, RT Silver, H Kantarjian Blood, The Journal of the American Society of Hematology 127 (11), 1398-1402, 2016 | 60 | 2016 |
| Against Cyberproperty MA Carrier, G Lastowka Berkeley Tech. LJ 22, 1485, 2007 | 56 | 2007 |
| Why the Cope of the Patent Test cannot Solve the Drug Patent Settlement Problem MA Carrier Stan. Tech. L. Rev., 1, 2012 | 49 | 2012 |
